Acute Bilateral Uveitis, Hypotony, and Cataracts Associated with Ipilimumab and Nivolumab Therapy: Optical Coherence Tomography Angiography Findings

...ion and enhancement of the immune response against tumor cells. Since 2011, the Food and Drug Administration (FDA) has approved a number of ICI therapies, including immunoglobulin G1 (IgG1) anti-CTLA-4 human monoclonal a...
Read Full Article